Leerink Partners sets $23.00 share price target for Amneal Pharmaceuticals
Leerink Partners announced a $23.00 per-share price target for Amneal Pharmaceuticals, according to ratings actions cited by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.